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Warren J. Manning, MD*†
Boston, Massachusetts
O B J E C T I V E S We sought to determine the prevalence of noncardiac pathology in a large
consecutive series of patients referred for clinical cardiac magnetic resonance (CMR) studies.
B A C KG ROUND The imaging ﬁeld for many CMR sequences extends outside of the heart border.
As a result, noncardiac pathology may be identiﬁed. These noncardiac ﬁndings have clinical signiﬁcance
because they often lead to subsequent imaging/testing and intervention. The prevalence of noncardiac
ﬁndings on clinical CMR studies has not been well described.
METHOD S The reports of all 1,534 (62% male, age 50  15 years) clinical CMR studies performed
at an academic medical center during calendar years 2002 to 2006 were reviewed. All studies had been
interpreted by both a staff cardiologist (level III trained in CMR) and a board-certiﬁed radiologist (with
fellowship training in CMR). For each study, sex, age, indication for CMR study, and reported noncardiac
pathology were extracted. Follow-up for each major noncardiac pathology was evaluated by reviewing
the patient’s medical center electronic medical record. These noncardiac pathologies were then
categorized as signiﬁcant if an intervention or change in the patient’s management ensued.
R E S U L T S A total of 116 (7.6%) studies had at least one noncardiac ﬁnding. These ﬁndings included
55 major ﬁndings (e.g., lymphadenopathy, lung abnormalities, mediastinal masses) in 48 distinct reports
(prevalence of 3.1%) and 74 minor ﬁndings (e.g., small pleural effusions, liver cysts, renal cysts) in 70
distinct reports (prevalence of 4.6%). The majority (62%) of major ﬁndings were previously known, with
only 8 ﬁndings in 6 (0.4%) of 1,534 reports ultimately deemed to be new and clinically important/
signiﬁcant. The age of those with noncardiac pathology was greater (54  16 years vs. 49  16 years,
p  0.001).
CONC L U S I O N S In this large series of consecutive clinical CMR studies interpreted by both staff
cardiologists and radiologists, noncardiac pathology is uncommonly reported. When reported, the
majority of major ﬁndings are previously known. New major ﬁndings were detected in 0.5% of
reports. (J Am Coll Cardiol Img 2009;2:980–6) © 2009 by the American College of Cardiology
Foundation
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981ardiac magnetic resonance (CMR) has
been used increasingly to evaluate a variety
of cardiac conditions, including biventricular
volumes/ejection fraction, viability, coro-
ary artery disease, valvular function, congenital
eart disease, cardiomyopathy, and pericardial pa-
hology (1–8). The extent to which other thoracic
nd upper abdominal organs are captured by this
maging technique leads to the possibility of
dentifying noncardiac pathology. Such findings
ould lead to either identifying previously undiag-
osed pathology or recommending further testing
hat may be associated with additional cost, mor-
idity or patient anxiety. Although the frequency of
eported noncardiac pathology has been well de-
cribed for patients undergoing electron beam CT
nd multidetector computed tomography (MDCT)
or assessment of epicardial coronary calcium
9–14), the prevalence of noncardiac pathology in
linical CMR has not been as well described. We
ought to evaluate the rate at which major and
inor noncardiac pathology are reported in a large
onsecutive series of clinical CMR studies.
E T H O D S
atients. The reports of 1,534 consecutive clinical
MR studies performed at a single academic med-
cal center during calendar years 2002 to 2006 were
eviewed. Studies are interpreted in a joint (or
erial) reading session attended by staff cardiologists
Level III-trained in CMR) and board-certified
adiologists who had completed a fellowship in
agnetic resonance (MR). Standardized reports
ncluded descriptive details of each scan as well as a
ummary of all findings. This retrospective study
as approved by the hospital Committee on Clin-
cal Investigation, which waived informed consent.
MR. Clinical CMR studies were conducted by the
se of a standardized protocol based on indication
Table 1). All studies included serial thoracic scout
mages (fast gradient echo axial, coronal, sagittal),
ssessment of left ventricular and right ventricular
ystolic function by the use of breath-hold cine
teady-state free precession sequences, and an axial
tack of T1-weighted electrocardiogram-triggered
ast-spin echo images of the thorax. Additional
equences (e.g., T2-weighted fast-spin echo, late
adolinium enhancement, myocardial tagging, pul-
onary vein angiography, coronary imaging) were
erformed as dictated by the clinical indication for
MR. Sixty-three percent of patients received 0.1 so 0.2 mmol/kg of intravenous gadopentetate di-
eglume (Magnevist, Bayer Pharmaceuticals,
ayne, New Jersey), primarily those referred for
ssessment of pulmonary vein anatomy, cardiomy-
pathy, myocardial viability, pericardial disease, and
ardiac mass assessment.
ata analysis. For each CMR report, the
ubject’s age, sex, indication(s) for CMR,
nd any noncardiac pathology were ex-
racted. Noncardiac pathology was classi-
ed as “major” if it was more likely to
equire further follow-up (e.g., lymphade-
opathy, lung abnormalities, mediastinal
asses, breast lesions, ascites, and soft-
issue masses). Minor noncardiac pathol-
gy was considered to more likely be
enign and not require specific follow-up
e.g., small pleural effusion, benign liver
esion [cyst or hamartomas], renal cyst, hiatal her-
ia, diaphragmatic abnormality, splenic abnormal-
ty, paraspinal lipoma, and anomalous vasculature).
ollow-up. To assess the clinical impact of the
ajor noncardiac pathology, the medical center’s
lectronic medical record through February 2009 of
ach patient with major pathology was reviewed.
ollow-up was deemed to have occurred if a sub-
equent imaging study was performed to further
valuate the new finding. A finding was considered
reviously known if it was referenced in a previous
maging study or office note. A finding was consid-
red clinically significant if it led to a new diagnosis
nd/or an intervention or change in patient
anagement.
tatistics. All data are presented as mean  SD.
revalence was described by absolute number as
ell as percentage. Comparisons were performed by
tandard t test and the Fisher exact test with a
Table 1. Indications for Which Evaluation Was Requested
by Cardiac Magnetic Resonance in the 1,534 Study Reports
Ventricular function 517 (34)
Pulmonary vein anatomy 386 (25)
Cardiomyopathy 362 (24)
Valvular disease 252 (16)
Coronary artery assessment 151 (10)
Myocardial viability 116 (8)
Congenital heart disease 105 (7)
Pericardial disease 59 (4)
Other 120 (8)
Studies could have more than 1 indication. Data are presented as n (%) of
reports.
A B B
A N D
CCT
tomog
CMR
reson
CT
MDCT
comp
MRtatistical significance level of p  0.05.R E V I A T I O N S
A C R O N YM S
cardiac computed
raphy
cardiac magnetic
ance
computed tomography
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982E S U L T S
f the 1,534 studies, 62% were performed in male
atients. Age ranged from 10 to 89 years, mean 50
5 years. Indications for CMR (multiple potential
ndications for each study) are summarized in Table 1.
he most common included assessment of ventricular
unction (34%), pulmonary vein assessment (25%),
nd evaluation of cardiomyopathy (24%). The age of
hose with noncardiac pathology was greater than
hose without (54  16 years vs. 49  16 years, p 
.001). There was no significant difference in sex.
A total of 129 noncardiac findings were reported
n 116 (prevalence of 7.6%) studies, including 55
ajor findings in 48 studies (prevalence of 3.1%)
nd 74 minor findings in 70 studies (prevalence of
.6%). Figure 1 shows the distribution of major
ndings. The most common major findings in-
luded lymphadenopathy (n  22, 40%), lung
bnormalities (e.g., nodules, masses, and infiltrates;
 19, 35%), and mediastinal masses (n  6,
1%). Examples of noncardiac major pathology are
hown in Figures 2 to 5. There was no correlation
f CMR indication with the finding of noncardiac
athology.
The distribution of minor findings across all 74
nstances is displayed in Figure 6. The most com-
on noncardiac minor pathologies were small pleu-
al effusions (n  30, 40%), benign liver cysts or
amartomas (n  15, 20%), and renal cysts (n 
4, 19%). An example of noncardiac minor pathol-
gy is the simple liver cyst shown in Figure 7.
Follow-up clinical data were available on 52
95%) of the 55 major noncardiac findings in 45
2%%
35%
40%
Lymphadenopathy (n = 22)
Lung abnormality (n = 19)
Mediastinal mass (n = 6)
Breast lesion (n = 4)
Ascites (n = 3)
Soft tissue mass (n = 1)
istribution of Major Noncardiac Pathology
istribution of the individual major noncardiac pathologies identi-
diac magnetic resonance scanning. These ﬁndings were noted in
reports for an overall prevalence of 3.1%. Lymphadenopathy and
malities were the most common. Data are presented with the
major noncardiac ﬁndings, with the pie chart demonstrating the
total major noncardiac ﬁndings.94%) of 48 patients. The majority (62%; 29 of 50) cf major findings were previously known, whereas
3 were deemed clinically unimportant or not
onfirmed (e.g., lung abnormality not confirmed by
Figure 2. Example of Major Noncardiac Pathology
An example of major noncardiac pathology. Axial T2-weighted fast-
spin echo fat-suppressed cardiac magnetic resonance images in a
patient with previously unrecognized Hodgkin’s lymphoma. Note
the marked and diffuse increase in mediastinal lymphadenopathy
(white areas within yellow circles), which represent prominent
lymph nodes. Subsequent biopsy conﬁrmed Hodgkin’s lymphoma.5
7%
11%
Figure 1. D
Pie chart d
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983tudy. The remaining 8 major findings in 6 distinct
eports (0.4% of all 1,534 reports) led to a new
iagnosis and/or change in patient management).
hese findings included a nonsmall cell lung cancer
ith lymphadenopathy, expanding pulmonary nod-
les with lymphadenopathy leading to bronchos-
opy and a new diagnosis of pulmonary malignancy,
pulmonary infarction, a cryptogenic organizing
neumonia, and a pulmonary carcinoid.
I S C U S S I O N
n this large consecutive series of 1,534 consecutive
linical CMR studies, the reported prevalence of
ny noncardiac pathology was 10%, with only 3%
epresenting major findings. The majority of major
Figure 3. Example of Major Noncardiac Pathology
(A) Balanced cine steady-state free precession cardiac magnetic
resonance (CMR) in the double oblique 4-chamber orientation
and (B) axial T2-weighted fast spin echo axial image with fat
saturation (no exogenous contrast). A lung mass (bright white
mass within the yellow circle) on the T2-weighted fast spin
echo axial image is readily apparent. Although present, the
abnormality is more subtle on the balanced steady-state free
precession image. This highlights the potential of noncardiac
pathology to be masked using some of the common CMR
sequences. Subsequent evaluation determined this to be a pul-
monary carcinoid tumor.oncardiac pathologies were previously known withFigure 4. Example of Major Noncardiac Pathology
(A) Axial T2-weighted fast spin-echo image, (B) balanced cine
steady-state free precession cardiac magnetic resonance (CMR)
in the double-oblique short axis orientation, and (C) large gado-
linium enhancement (ﬁbrosis imaging 15 min after administra-
tion of 0.2 mmol/kg of gadolinium) CMR in the same short axis
orientation as (B). Note the lesion in the breast which is “dark”
on fast spin echo and steady-state free precession and then
“bright” after gadolinium contrast. Subsequent biopsy demon-
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appearance is suggestive of multifocal pneumonia. Subsequent biopsy
strating the percent of total minor noncardiac ﬁndings.
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9840.5% of all reports representing new major non-
ardiac findings of clinical significance.
Our results contrast to studies examining the
revalence of noncardiac findings in cardiac com-
uted tomography (CCT). Hunold et al. (12) found
xtra-coronary abnormalities in 53% of 1,812 pa-
ients who underwent electron beam CT for the
ssessment of coronary artery calcification (12),
hereas Onuma et al. (13) reported that 58% of 503
atients who underwent MDCT of the heart had
ew, noncardiac pathology. In 2 smaller studies,
ewey et al. (9) found 16 (15%) of 108 patients had
oncardiac pathology on coronary artery CT imag-
ng, whereas Haller et al. (10) found noncardiac
athology in 25% of 166 patients who underwent
ontrast-enhanced MDCT. Finally, a retrospective
tudy by Schragin et al. (14) found 20.5% of 1,356
ubjects who had undergone electron beam CT for
oronary artery calcification had 1 or more noncar-
iac pathology.
In our study, only 3% of studies were found to
the patchy and diffuse intermediate signal intensity within the
ies are dependent (as would be expected with atelectasis). The
demonstrated cryptogenic organizing pneumonia.Figure 5. Example of Major Noncardiac Pathology
Series of 4 axial T2-weighted fast spin-echo images of the thorax. Note
right lung ﬁeld. More opacities are seen on the right, and not all opacit3%3%
3%
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Figure 6. Distribution of Minor Noncardiac Pathology
A pie chart distribution of the individual minor noncardiac pathologies iden-
tiﬁed on cardiac magnetic resonance scanning. These ﬁndings were noted in
70 distinct reports for an overall prevalence of 4.6%. Pleural effusions and
benign liver and renal cysts were the most common. Data are presented
with the number of minor noncardiac ﬁndings with the pie chart demon-ave major noncardiac findings. This frequency is
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985imilar to analogous CCT studies by Schragin et al.
14), Haller et al. (10), and Dewey et al. (9), who
eported a prevalence of significant noncardiac pa-
hology on CCT of 4.2%, 4.8%, and 5%, respec-
ively. Slightly greater rates were found in the
eports of Horton et al. (11), Hunold et al. (12), and
numa et al. (13) at 7.8%, 11%, and 22.7%,
espectively.
There are few data regarding noncardiac findings
n CMR studies. To our knowledge, our study is
Figure 7. Example of Minor Noncardiac Pathology
Double oblique cardiac magnetic resonance (CMR) imaging
using (A) cine steady-state free precession and (B) late gadolin-
ium enhancement CMR imaging in the same orientation. The
abnormality (yellow circle) is “bright” in the cine steady state
free precession sequence (A), suggesting a cystic (or vascular)
structure. The dark appearance on late gadolinium enhance-
ment CMR is consistent with a cyst (B).he first to examine the prevalence of noncardiac Mndings in a large consecutive series of patients
eferred for clinical CMR for a broad range of
ndications. In a smaller study of 108 patients
ndergoing coronary MR, Dewey et al. (9) reported
(2%) significant noncardiac findings and 7 (6%)
nsignificant noncardiac findings, values that are
imilar to our data in a population referred for a
roader spectrum of indications. McKenna et al.
17) reported on noncardiac pathology among a
roup of 107 predominantly male subjects who
nderwent a screening CMR for research using
imilar CMR sequences. Images were specifically
eviewed for noncardiac pathology. The authors
ound 81% of their subjects had noncardiac pathol-
gy, including 17% with potentially significant pa-
hology (17). The difference in noncardiac pathol-
gy prevalence is likely related to their unusual
opulation and different methodology, including a
edicated image review for noncardiac pathology.
ur population is likely to be more reflective of those
eferred for clinical CMR. In addition, no data were
eported by McKenna et al. (17) as to whether the
athology was “previously known,” nor was follow-up
rovided to know the true impact of whether the
athologies had an impact on patient care.
The lower prevalence of noncardiac findings in
ur study as compared with those in CCT might be
xplained by several issues. Criteria for reporting of
inor findings in our study were not specified
rospectively. The reporting of benign noncardiac
ndings may have been influenced by a given
eaders decision to include (or not include) findings
hat would not impact the patient’s care. CT has
reater spatial resolution and is generally considered
o be superior to CMR in detecting pulmonary
athology. Unlike CT, the CMR examination does
ot capture the entire chest, and CMR sequences
re not optimized for noncardiac pathology. Our
ata suggest that physicians referring their patients
or CMR should be aware that noncardiac pathol-
gy is unlikely to be reported (as compared with
CT for which noncardiac pathology is very com-
on). Although the number of clinically important
ndings is likely to be very low, this does not
bviate the need for interpreting physicians to be
ware of noncardiac pathology.
The identification of noncardiac pathology is
ikely influenced by the training of interpreting
hysicians and the reading session style. Our clin-
cal studies are interpreted at a joint reading session
or serial independent reading sessions) attended by
oard-certified radiologists who have completed
R fellowship and Level III-trained CMR cardi-
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986logists. Many centers have CMR study interpre-
ations performed by a radiologist or a cardiologist.
reliminary data do suggest that more noncardiac
ndings are reported in a joint imaging session as
ompared with serial interpretation (separate cardi-
logist and radiologist interpretations) (18). Cur-
ent CMR training guidelines (15,16) do not in-
lude specific training in noncardiac pathologies.
lthough there was a small percentage of noncar-
iac findings that led to a new diagnosis, some of
hese were of critical importance, including the
nitial detection of cancer that may have otherwise
ot been discovered. A better understanding of how
arious sequences impact the ability to detect non-
ardiac pathology would help the development of
uidelines in CMR training. The clinical impact of
hese noncardiac findings appears to be small. Our
ollow-up data show only 0.4% of all reports led to
new diagnosis, although these diagnoses included
nitial detection of cancer that may have otherwise
ot been detected.
tudy limitations. Our study has several limitations. It
s a retrospective review of clinical reports and the
linical impact of the major noncardiac pathology wastion 2005;112:135–44. electron beam comecord at our institution. This electronic medical
ecord has been in use for20 years and includes both
npatient and outpatient visits and reports; however,
urther evaluation performed or not referenced by
hysicians at our institution would not be captured. In
ddition, the categorization of major and minor find-
ngs was subjective. Other studies have used the
efinition of a significant finding as one that results in
urther imaging or change in treatment.
O N C L U S I O N S
n this large review of consecutive clinical CMR
eports interpreted by both staff cardiologists and
adiologists, noncardiac findings were uncommonly
eported, with the majority being previously known.
urther study is needed to elucidate the optimiza-
ion of detection of noncardiac findings as well as
he impact of these incidental findings on clinical
ractice and patient outcomes.
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